W. Garvey
Public Health, Environmental and Occupational Health · 2003–2022
A researcher in the Science corpus: 12 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Public Health, Environmental and Occupational Health — 100 citations into it
Whom W. Garvey trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Cynthia L Ogden
- K. Flegal
- M. Carroll
- Asheley Skinner
- R. Wing
- B. Kit
- J. Skelton
- T. Young
- Paul E. Peppard
Papers from W. Garvey's perspective
Ordered by how strongly the researchers W. Garvey trusts endorse each paper. Same corpus, a different order for every researcher.
- Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric Surgery
- Prevalence and trends in obesity among US adults, 1999-2008. (Journal of the American Medical Association (JAMA))
- Bariatric surgery: a systematic review and meta-analysis. (Journal of the American Medical Association (JAMA))
- [Bariatric surgery versus conventional medical therapy for type 2 diabetes]. (Revista clínica española (Ed. impresa))
- Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. (Journal of the American Medical Association (JAMA))
- Effects of bariatric surgery on mortality in Swedish obese subjects. (New England Journal of Medicine)
- Obesity in adults: a clinical practice guideline (Canadian Medical Association Journal)
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. (Journal of Medicinal Chemistry)
- Overweight as an avoidable cause of cancer in Europe (International Journal of Cancer)
- The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. (The Lancet)
Their papers
- Tirzepatide Once Weekly for the Treatment of Obesity. (2022) — 2,502 citations
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. (2022) — 790 citations
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). (2022) — 814 citations
- Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial (2022) — 705 citations
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. (2021) — 897 citations
- Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Me (2019) — 829 citations
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) — 1,140 citations
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. (2016) — 1,549 citations
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015 — EXECUTIVE SUMMARY (2015) — 624 citations
- CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITIONAL, METABOLIC, AND NONSURGICAL SUPPORT OF THE BARIATRIC SURGERY PATIENT—2013 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, THE OBESITY SOCIETY, AND AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY (2013) — 2,165 citations
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) (2011) — 629 citations
- Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. (2003) — 608 citations